Pathstone Holdings LLC Has $8.69 Million Stake in Synopsys, Inc. (NASDAQ:SNPS)

Pathstone Holdings LLC decreased its holdings in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 6.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,899 shares of the semiconductor company's stock after selling 1,179 shares during the quarter. Pathstone Holdings LLC's holdings in Synopsys were worth $8,688,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Mufg Securities Americas Inc. acquired a new stake in shares of Synopsys during the fourth quarter valued at $1,101,000. Nissay Asset Management Corp Japan ADV grew its stake in Synopsys by 4.8% during the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 41,279 shares of the semiconductor company's stock worth $20,264,000 after buying an additional 1,877 shares during the last quarter. Nan Shan Life Insurance Co. Ltd. increased its holdings in shares of Synopsys by 2.3% during the fourth quarter. Nan Shan Life Insurance Co. Ltd. now owns 89,155 shares of the semiconductor company's stock valued at $43,272,000 after purchasing an additional 1,967 shares during the period. NorthRock Partners LLC purchased a new stake in Synopsys in the 4th quarter worth about $640,000. Finally, Nuveen Asset Management LLC lifted its holdings in shares of Synopsys by 12.1% during the 4th quarter. Nuveen Asset Management LLC now owns 1,691,501 shares of the semiconductor company's stock valued at $820,987,000 after buying an additional 182,115 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.

Synopsys Trading Down 0.1%

NASDAQ SNPS traded down $0.40 on Tuesday, hitting $515.61. 740,736 shares of the company's stock traded hands, compared to its average volume of 1,107,857. The firm has a market capitalization of $79.72 billion, a PE ratio of 35.51, a P/E/G ratio of 3.23 and a beta of 1.16. The firm's 50-day moving average price is $446.11 and its two-hundred day moving average price is $488.94. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $624.80.

Insider Activity

In other Synopsys news, insider Geus Aart De sold 15,705 shares of the firm's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the transaction, the insider now owns 116,671 shares of the company's stock, valued at approximately $51,850,925.82. This trade represents a 11.86% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the transaction, the chief executive officer now owns 70,922 shares in the company, valued at approximately $32,890,077.50. The trade was a 13.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.62% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Wells Fargo & Company lowered their price objective on Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a research report on Thursday, February 27th. Morgan Stanley decreased their price objective on Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a research note on Monday, February 24th. Bank of America reduced their price target on shares of Synopsys from $630.00 to $560.00 and set a "buy" rating on the stock in a research report on Wednesday, April 16th. Needham & Company LLC reaffirmed a "buy" rating and set a $650.00 target price on shares of Synopsys in a report on Thursday, February 27th. Finally, KeyCorp raised their target price on shares of Synopsys from $555.00 to $575.00 and gave the stock an "overweight" rating in a report on Tuesday. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $614.86.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.